# US 5,700,458 A · Acid-functionalized saccharides as polyvalent anti-infectives > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 5,700,458 A - Document ID: US5700458A - Status: Granted - Kind: A - Application number: 08/717,264 - Filed: 1996-09-20 - Granted: 1997-12-23 - Earliest claimed: 1996-09-20 - Assignees: GelTex Pharmaceuticals, Inc. - Inventors: W. Harry Mandeville, III; Venkata R. Garigapati - Web page: https://patentgrep.com/patent/US5700458A ## CPC - A61K 31/785: Polymers containing nitrogen - C08F 20/28: containing no aromatic rings in the alcohol moiety - C08F 20/38: Esters containing sulfur - C08F 20/58: containing oxygen in addition to the carbonamido oxygen {, e.g. N-methylolacrylamide, N-acryloylmorpholine} - Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) - C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS - Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE ## Abstract The present invention includes polymerizable monomers comprising an acid-functionalized glycoside moiety. In one embodiment, the monomer has a polymerizable functional group, such as an olefinic bond, to which the acid-functionalized glycoside moiety is attached by a spacer group, for example, an alkylene group, or an alkylene group wherein one or more carbon atoms are substituted by heteroatoms, such as oxygen, nitrogen or sulfur atoms. The present invention also includes polymers comprising one or more acid-functionalized glycoside moieties, such as pendant acid-functionalized glycoside moieties, which can inhibit or prevent rotavirus infection in a mammal. Such a polymer can comprise, for example, a monomer of the present invention. The polymer can be a homopolymer or a copolymer, and can have, for example, a polyacrylamide, polyacrylate or polystyrene backbone. In another embodiment, the present invention comprises a method for treating a rotaviral infection in a mammal, for example, a human, by administering to the mammal a therapeutically effective amount of a polymer comprising one or more glycoside moieties, such as pendant glycoside moieties. The polymer can be a homopolymer or a copolymer. In one embodiment, the polymer is a copolymer which comprises an acid-functionalized glycoside-bearing monomer and acrylamide. ## Claims ### Claim 1 A method for treating a microbial infection in a mammal, comprising administering to the mammal a therapeutically effective amount of a polymer comprising a polymerized monomer having one or more acid-functionalized glycoside moieties. ### Claim 2 (depends on 1) The method of claim 1 wherein the acid functional group is an --OSO.sub.3 H group or an --OCH.sub.2 COOH group. ### Claim 3 (depends on 1) The method of claim 1 wherein the polymer further comprises a backbone selected from the group consisting of polyacrylamide, polyacrylate, polystyrene, poly(allylamine), poly(allyl alcohol), poly(vinylamine) and poly(vinyl alcohol). ### Claim 4 (depends on 1) The method of claim 1 wherein the polymer comprises a monomer of Formula I, ##STR3## wherein R.sub.6 is a hydrogen atom or a hydroxyl group, and one of R.sub.2, R.sub.3 and R.sub.4 is an --SO.sub.3 H group or a --CH.sub.2 COOH group or a salt thereof, and the remainder are each a hydrogen atom; or R.sub.6 is --OSO.sub.3 H or --OCH.sub.2 COOH or a salt thereof and R.sub.2, R.sub.3 and R.sub.4 are each a hydrogen atom; the glycoside moiety is an .alpha.- or .beta.-L-glycoside moiety or an .alpha.or .beta.-D-glycoside moiety; X is a straight chain or branched, substituted or unsubstituted alkylene group, wherein, optionally, one or more carbon atoms can be substituted by a heteroatom; Y is CH.sub.2, NH, an oxygen atom or a sulfur atom; z is an amidocarbonyl, oxycarbonyl, phenylene, amino, aminomethylene, group, or an oxygen atom; and R is a hydrogen atom or a methyl or ethyl group. ### Claim 5 (depends on 1) The method of claim 1 wherein the polymer comprises a monomer of Formula I. ##STR4## wherein R.sub.6 is a hydrogen atom or a hydroxyl group, and one of R.sub.2, R.sub.3 and R.sub.4 is an --SO.sub.3 H group or a --CH.sub.2 COOH group or a salt thereof, and the remainder are each a hydrogen atom; or R.sub.6 is --OSO.sub.3 H or --OCH.sub.2 COOH or a salt thereof and R.sub.2, R.sub.3 and R.sub.4 are each a hydrogen atom; the glycoside moiety is an .alpha.- or .beta.-L-glycoside moiety or an .alpha.- or .beta.-D-glycoside moiety; X is a straight chain or branched, substituted or unsubstituted alkylene group, wherein, optionally, one or more carbon atoms can be substituted by a heteroatom; Y is CH.sub.2, NH, an oxygen atom or a sulfur atom; Z is an amidocarbonyl, oxycarbonyl, phenylene, amine, or aminomethylene group, or an oxygen atom; x, y, and z are each, independently, 0 or 1; and R is a hydrogen atom or a methyl or ethyl group. ### Claim 6 (depends on 4) The method of claim 4 wherein the glycoside moiety is selected from the group consisting of fucoside, alloside, altroside, glucoside, mannoside, guloside, idoside, and taloside. ### Claim 7 (depends on 6) The method of claim 6 wherein the acid-functionalized glycoside moiety is a 3-O-sulfogalactoside moiety. ### Claim 8 (depends on 6) The method of claim 6 wherein the polymer is a copolymer. ### Claim 9 (depends on 8) The method of claim 8 wherein the copolymer further comprises a hydrophobic monomer. ### Claim 10 (depends on 9) The method of claim 9 wherein the hydrophobic monomer comprises a normal or branched, substituted or unsubstituted C.sub.3 -C.sub.18 -alkyl group or an aryl or substituted aryl group and the alkyl or aryl substituents. ### Claim 11 (depends on 10) The method of claim 10 wherein the hydrophobic monomer is an N-(C.sub.3 -C.sub.18 -alkyl) acrylamide. ### Claim 12 (depends on 11) The method of claim 11 wherein the hydrophobic monomer is selected from the group consisting of N-n-decylacrylamide and N-isopropylacrylamide. ### Claim 13 (depends on 9) The method of claim 9 wherein the copolymer further comprises a neutral hydrophilic monomer. ### Claim 14 (depends on 13) The method of claim 13 wherein the neutral hydrophilic monomer is acrylamide or N-(2-hydroxyethyl)acrylamide. ### Claim 15 (depends on 4) The method of claim 4 wherein the copolymer comprises from about 5 mole percent to about 50 mole percent of a monomer of Formula I. ### Claim 16 (depends on 15) The method of claim 15 wherein the copolymer comprises from about 20 mole percent to about 30 mole percent of a monomer of Formula I.